Importance of estrogen metabolites

Hypertension

Volumn 64, Issue 1, 2014, Pages 21-22

  Lindsey, Sarah H ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; 26 HYDROXYCHOLESTEROL; ANGIOTENSIN II; CATECHOL; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CHOLESTANETRIOL 26 MONOOXYGENASE; CONJUGATED ESTROGEN; CYTOCHROME P450 1B1; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; HYDROXYSTEROID DEHYDROGENASE;

BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; ESTROGEN METABOLISM; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MOUSE MODEL; NONHUMAN; NOTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ESTRADIOL; FEMALE; HYPERTENSION;

EID: 84902545283     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03382     Document Type: Note

References (11)

1. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:7.
2. Jennings BL, George LW, Pingili AK, Khan NS, Estes AM, Fang XR, Gonzalez FJ, Malik KU. Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female mice. Hypertension. 2014;64: 134-140.
3. Dubey RK, Jackson EK. Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol Metab. 2009;20: 374-379.
4. Koganti S, Snyder R, Gumaste U, Karamyan VT, Thekkumkara T. 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. Eur J Pharmacol. 2014;723: 131-140.
5. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13: 1185-1192.
6. Degen GH, McLachlan JA, Eling TE, Sivarajah K. Cooxidation of steroidal and non-steroidal estrogens by purified prostaglandin synthase results in a stimulation of prostaglandin formation. J Steroid Biochem. 1987;26: 679-685.
7. White K, Johansen AK, Nilsen M, Ciuclan L, Wallace E, Paton L, Campbell A, Morecroft I, Loughlin L, McClure JD, Thomas M, Mair KM, MacLean MR. Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension. Circulation. 2012;126: 1087-1098.
8. Gaikwad NW, Yang L, Pruthi S, Ingle JN, Sandhu N, Rogan EG, Cavalieri EL. Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer (Auckl). 2009;3: 1-8.
9. Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, Xu X, Hankinson SE. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18: 2860-2868.
10. Bhavnani BR. The saga of the ring B unsaturated equine estrogens. Endocr Rev. 1988;9: 396-416.
11. Kim JH, Meyers MS, Khuder SS, Abdallah SL, Muturi HT, Russo L, Tate CR, Hevener AL, Najjar SM, Leloup C, Mauvais-Jarvis F. Tissueselective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol Metab. 2014;3: 177-190.